EverSource Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Sell
11,434
-2,393
-17% -$515K 0.1% 175
2026
Q1
$3.01M Buy
13,827
+1,817
+15% +$403K 0.09% 166
2025
Q4
$2.74M Buy
12,010
+1,373
+13% +$313K 0.1% 160
2025
Q3
$2.46M Buy
10,637
+55
+0.5% +$11.2K 0.1% 154
2025
Q2
$1.96M Sell
10,582
-973
-8% -$181K 0.09% 167
2025
Q1
$2.42M Buy
11,555
+737
+7% +$143K 0.13% 135
2024
Q4
$1.92M Buy
10,818
+1,119
+12% +$206K 0.11% 154
2024
Q3
$1.92M Buy
9,699
+1,037
+12% +$194K 0.12% 145
2024
Q2
$1.61M Buy
8,662
+1,857
+27% +$308K 0.11% 153
2024
Q1
$1.11M Buy
6,805
+1,943
+40% +$335K 0.09% 168
2023
Q4
$754K Sell
4,862
-4,047
-45% -$590K 0.07% 195
2023
Q3
$1.33M Sell
8,909
-655
-7% -$96.2K 0.14% 134
2023
Q2
$1.29M Buy
9,564
+3,065
+47% +$449K 0.14% 133
2023
Q1
$1.04M Sell
6,499
-116
-2% -$17.7K 0.13% 136
2022
Q4
$1.07M Buy
6,615
+1,420
+27% +$218K 0.16% 115
2022
Q3
$698K Sell
5,195
-470
-8% -$67.4K 0.16% 121
2022
Q2
$868K Sell
5,665
-422
-7% -$64.5K 0.22% 80
2022
Q1
$987K Buy
6,087
+3,327
+121% +$483K 0.25% 70
2021
Q4
$374K Buy
+2,760
New +$326K 0.1% 150

Other funds holding ABBV

EverSource Wealth Advisors's ABBV Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $515K and leaving 11,434 shares worth $2.88M. The position accounts for 0.1% of the portfolio, ranked #175.

EverSource Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.01M in Q1 2026. 2,246 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EverSource Wealth Advisors held 11,434 shares of AbbVie worth $2.88M as of Q2 2026.
  • EverSource Wealth Advisors sold 2,393 AbbVie shares in Q2 2026, an estimated $515K.
  • AbbVie made up 0.1% of EverSource Wealth Advisors's portfolio in Q2 2026, its #175 holding.
  • EverSource Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's AbbVie position peaked at $3.01M in Q1 2026.
  • 2,246 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.